Back To The Future: Insurance Pools For High-Risk Patients Could Be Revived
Trump and leading Republicans like the idea. Some policymakers and experts say it wasn’t viable in the first place.
U.S. Congress
981-1,000 of 1,000 results
-
-
Long-Stalled FDA Reform Sits On Senate’s Lame-Duck Calendar
The legislation would give federal officials more flexibility in evaluating the effectiveness and safety of drugs and devices and add billions of dollars to NIH funding. But critics say it could endanger patients’ safety and doesn’t do enough to stop spiraling drug prices.
-
Blue Shield, California’s Biggest Obamacare Insurer, Vows It’s Not ‘Running For The Hills’
The company’s CEO also dismisses Trump’s notion of selling insurance plans across state lines, calling it ‘perplexing.’
By Chad Terhune -
Elections 2016
Millions Could Lose Medicaid Coverage Under Trump Plan
But block grants face likely resistance from states, poised to lose many millions.
-
Elections 2016
Repealing The Affordable Care Act Could Be More Complicated Than It Looks
Republicans will likely chip away at the ACA piecemeal and say they will try to provide a soft exit.
By Julie Rovner -
Elections 2016
Trump, GOP In Congress Could Use ‘Must-Pass’ Bills To Bring Health Changes
Some “must-pass” health legislation next year could give the new administration a vehicle for some proposals that might not be able to clear political or procedural hurdles on their own.
By Julie Rovner -
What Would A Public Insurance Option Look Like?
UCLA health policy expert Gerald Kominski says a “public option” health plan would look a lot like private insurance, and politics will determine whether it would happen on a state or national level.
-
A Bygone Era: When Bipartisanship Led To Health Care Transformation
A federal law enacted shortly after the end of World War II provided grants and loans to fund hospital construction that have left a lasting legacy.
-
The Orphan Drug Machine
A Golden Ticket That Fast-Tracks A Drug Through The FDA
A voucher awarded to companies that find treatments for rare childhood diseases can be sold to the highest bidder — and then used to speed up approvals for much more common drugs.
-
Congressman Decries Olympus’ Failure To Warn U.S. Hospitals About Tainted Scopes
U.S. Rep. Ted Lieu (D-Calif.) renews his call for tightened laws that would force manufacturers to notify the Food and Drug Administration when they issue safety warnings in other countries related to the design and cleaning of their devices.
By Chad Terhune -
Seven Remaining Obamacare Co-Ops Prepare Survival Strategies
Two-thirds of the federally funded co-ops created by the health law to sell health insurance to individuals and small employers have folded and those that remain are diversifying to stay alive.
-
NIH’s Fauci On Combating Zika: ‘You Have To Have The Resources To Act Quickly’
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, recently spoke with KHN’s Carmen Heredia Rodriguez about vaccine development and the ongoing fight in Congress over emergency funding.
-
Obama Renews Call For A Public Option In Health Law
The president made the proposal as part of a comprehensive look at the Affordable Care Act’s legacy in an article under his byline in the Journal of the American Medical Association.
By Julie Rovner -
House Panel Extends Funding For Medicare Program To Help Consumers
The decision runs counter to a Senate committee that voted to strip the $52 million appropriation for the State Health Insurance Assistance Program, which helps beneficiaries understand their Medicare coverage and helps them with billing issues.
By Susan Jaffe -
Gingrich, Kennedy Take On Opioid Addiction — The KHN Conversation
Patrick Kennedy, a former congressman from Rhode Island, and Newt Gingrich, who was once the House speaker, are advancing policies to combat this national crisis.
-
Most Americans Want More Federal Money To Stop Zika: Poll
Almost two-thirds say federal funds should help women in Zika-affected areas get access to abortion, family planning and contraception services, a new Kaiser Family Foundation survey finds.
-
A Primer: How The Fight Against Zika Might Be Funded
The Senate approved an amendment to a must-pass appropriations bill that provides $1.1 billion to combat the virus’s spread. A separate House proposal, which has drawn a veto threat from the White House, is also pending and it is not clear how they might compromise. But public health advocates say efforts are needed soon to fight the mosquito-based disease.
-
Senate Panel Kills Medicare Program That Offers Help On Enrollment, Billing Issues
It’s not clear yet if the full Senate or House will concur in the plan to cut funding for the State Health Insurance Assistance Program, which operates in all states and gives beneficiaries free advice on enrollment in drug and insurance plans, appealing coverage decisions and applying for financial subsidies.
By Susan Jaffe -
Urging Openness About Superbug Infections, Doctor Omits Cases In Own Hospital
In a respected medical journal, a specialist advises colleagues on protecting patients but doesn’t mention potential infections from a contaminated scope at his Philadelphia cancer center.
By Chad Terhune -
Reforming Federal Oversight Of Medical Devices Won’t Be Easy
Despite dozens of infections from medical scopes, an agreement on how to fix the FDA’s flawed regulation of the device industry remains elusive.
By Chad Terhune